Anthem Projecting Losses on ACA Plans This Year

Related Link: 

Anthem Inc. said it is now projected losses on its Affordable Care Act plans this year, a turnaround for a major insurer that had maintained a relatively optimistic tone about that business.

The Economy Is Again Under the Sway of Asset Prices

Related Link: 

The rise in wealth and asset prices underscores their increasing importance since the 1990s, and how vulnerable the economy remains to any shock that forces a sudden reassessment of their value, Greg Ip writes.

In China, Local Rivals Takes Bite Out of Apple's Revenue

Related Link: 

Apple has a China problem, and it may only worsen, as Chinese smartphone makers offer better products and appeal to consumers to buy homegrown hardware.

China's Taikang Life Insurance Takes Stake in Sotheby's

Related Link: 

Taikang Life Insurance Co. has disclosed a 13.5% stake in Sotheby’s, citing a “positive view” of the auction company’s prospects as well as potential interest in a board seat.

Whole Foods Profit Falls; Sales Slip

Related Link: 

Whole Foods Market Inc. on Wednesday gave weak projections for the current quarter, as it booked its fourth-consecutive decline in quarterly profit.

Forrest Mars Jr., Former Co-President of Food Giant, Dies at 84

Related Link: 

Forrest E. Mars Jr., a grandson of the founder of Mars Inc. who pushed to make M&M’s and other treats into global snacks, has died at age 84.

GlaxoSmithKline Helped and Hurt by Sterling's Post-Brexit Fall

Related Link: 

While Brexit provided an expected boost to core earnings for GlaxoSmithKline, it also led to a big write-down—the latest in a series of surprises stemming from Britain’s vote to leave the EU.

Facebook's Huge Crowd Pleaser

Related Link: 

The social-networking giant defies law of large numbers, showing benefits of scale.

Amgen Profit Rises 13%, 2016 Outlook Raised

Related Link: 

Amgen Inc. said its second-quarter earnings rose 13% on better-than-expected revenue growth, which was again driven by sales of key drugs such as Enbrel.

Teva, Allergan Get FTC Approval for Generics Purchase

Related Link: 

Teva Pharmaceutical Industries Ltd. on Wednesday won regulatory approval from the Federal Trade Commission for its acquisition of Allergan PLC’s generics business, conditioned upon Teva’s divestiture of 75 drugs to rivals.

Syndicate content